GSA CAPITAL PARTNERS LLP - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$341,000
-43.5%
56,673
-16.9%
0.04%
-30.6%
Q3 2021$604,000
+61.9%
68,205
+44.8%
0.06%
+47.6%
Q2 2021$373,000
+25.6%
47,097
+20.7%
0.04%
-14.3%
Q1 2021$297,000
+121.6%
39,006
+182.2%
0.05%
+122.7%
Q3 2020$134,00013,8230.02%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 37,500$225,0000.16%
SABBY MANAGEMENT, LLC 73,366$441,0000.06%
GSA CAPITAL PARTNERS LLP 56,673$341,0000.04%
GOODWIN DANIEL L 10,000$60,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 88,966$535,0000.01%
EMFO, LLC 1,666$10,0000.01%
Virtu Financial LLC 14,020$84,0000.01%
Retirement Group, LLC 1,129$17,0000.01%
BLAIR WILLIAM & CO/IL 86,866$522,0000.00%
Hartford Financial Management Inc. 598$4,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders